ArticleJournal of thoracic disease2026
Novel cardiac computed tomography-based preoperative indicator associated with intraoperative graft flow in coronary artery bypass grafting.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Graft flow in coronary artery bypass grafting (CABG) is linked with blood distribution of the target vessel. In this study, we aimed to develop a novel quantitative measurement of target coronary artery quality using coronary computed tomography angiography (CCTA) and investigate its correlation with intraoperative transit time flow measurement (TTFM). Methods: We enrolled 68 patients with CABG who underwent preoperative CCTA. Target coronary artery volume index (TCAVI) was calculated from CCTA images and measurements in 65 arterial and 94 venous bypass grafts. CCTA-TCAVI, representing total volume (mm Results: CCTA-TCAVI demonstrated a positive correlation with mean graft flow (MGF =0.222, P=0.005). TCAVI was linked with abnormal internal mammary artery (IMA) grafts [intraoperative MGF <20 mL/min and pulsatility index (PI) 5] and saphenous vein grafts (SVGs, <40 mL/min) and PI (5) odds ratio (OR =0.99, <1, P=0.004). Interquartile range (IQR) analysis revealed a significant correlation between abnormal SVG and TCAVI (P<0.001), but no correlation between abnormal IMA and TCAVI (P=0.91). Compared with previous predictive measurements, TCAVI correlated with graft flow(MGF =0.222, P=0.005). The cutoff value for CCTA-TCAVI was 200 mm Conclusions: TCAVI as a novel measurement may be useful to appropriately select the optimal target arteries at the time of CABG. It may have clinical potential to predict intraoperative abnormal venous grafts with high accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.